Fresh Influx of Private Funding Fuels Neutra’s Vertical Integration Drive
“This is a welcome event that strengthens our company and puts it in a better long-term position to compete and succeed in the marketplace,” said Sydney Jim, Neutra’s CEO. “This funding round gives us the ability to pursue our strategies and goals, as well as potentially expand our vision for the future. We had a very successful 2019; this private funding will help us towards an equally accomplished 2020.”
Earlier this year, Neutra released a statement detailing the company’s achievements towards vertical integration over the preceding 12 months. These successes most notably included the VIVIS acquisition, among others.
Neutra Corp. and its subsidiary VIVIS produce hemp-based CBD products such as oils, lotions and creams.
CBD is a natural, multi-purpose hemp compound believed to offer a wide range of medical benefits. Users report relief from anxiety, lessening of the effects of seizures, slowing of neurodegenerative disorders, pain relief, and alleviation of certain cancer treatment side effects. Hemp-extracted CBD consumers also don’t face the dangers of addiction, in contrast to opioid users.
Due to this, the CBD market has exploded, leading the Hemp Business Journal to forecast sales of hemp-derived products to reach $22 billion by 2022. In comparison, the same market posted sales of $390 million last year.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Corp. (NTRR) is an early-stage research and development company that’s bringing modern healthy living solutions to a multi-billion dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving Hemp-based CBD market, in which we intend to participate.
CONTACT:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp.
View source version on accesswire.com:
https://www.accesswire.com/575158/Fresh-Influx-of-Private-Funding-Fuels-Neutras-Vertical-Integration-Drive
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com